{"disease":{"id":"house-dust-mite-rhinitis","name":"house dust mite rhinitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06920771","title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":552,"lead_sponsor_name":"HAL Allergy","has_results":false},{"nct_id":"NCT05525650","title":"Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":54,"lead_sponsor_name":"RAPHAS","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}